HOME >> MEDICINE >> NEWS
Emory University will conduct clinical trial of anthrax vaccine regimen

Emory University is one of five sites nationwide selected by the Centers for Disease Control and Prevention (CDC) to conduct a clinical trial of an anthrax vaccination regimen. The study, which is now enrolling volunteers, will use the anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA) in 1970. The new trial is designed to test whether changing the injection method from subcutaneous (under the skin) to the muscle or decreasing the number of doses affects the quality of the immune response or local reactions to the vaccine.

Harry Keyserling, M.D., professor of pediatric infectious diseases at Emory University School of Medicine, is principal investigator for the Emory study. Other sites include Baylor College of Medicine; the Mayo Clinic; the University of Alabama at Birmingham; and Walter Reed Army Medical Center.

Anthrax is a disease caused by the Bacillus anthracis germ, and most often is found in cattle and sheep. Infection with anthrax bacteria may cause skin sores and intestinal or lung illness. Intestinal or lung illness is often serious and may be fatal. Individuals become infected with anthrax when they eat or touch animal parts that contain the bacteria or when they eat, touch or breathe bacteria in the air or on the ground.

The last human clinical trials of the anthrax vaccine were conducted in the 1950s in goat mill workers and in the laboratory scientists who studied anthrax. In 1991, with the threat of Iraqi bioweapons during the Persian Gulf War, the US military began vaccinating soldiers headed to the Persian Gulf. A shortage of vaccine and an exhaustive vaccination schedule that stretched over several years required many soldiers to complete their anthrax immunizations on the battlefield. In 1998, after assessing the threat of biological weapons, the Department of Defense required all U.S. armed forces to receive the anthrax vaccine. More than two million people, mostly in the military, hav
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
14-May-2002


Page: 1 2 3

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory researchers find race and gender gaps in treatment of heart attack
7. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
8. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
9. Emory scientists find marker for long-term immunity
10. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
11. Emory scientists link atrial fibrillation with decrease in nitrous oxide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/16/2019)... ... March 16, 2019 , ... Blood Flow ... Ligament (ACL) reconstruction patients often face bone and muscle loss immediately following the ... note that combining blood flow restriction (BFR) therapy with traditional rehabilitation efforts may ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... announced the launch of its newly designed healthcare website, SMG3RX.com. Integrating a vibrant ... easily find a solution that fits their needs. , “We are thrilled to ...
(Date:3/15/2019)... ... March 15, 2019 , ... Esteemed Marietta dentist Dr. Michael ... Dental Assisting . The private dental assistant school is recognized as one of the ... a position within sixty days of graduation. Assisting 101 - School of Dental Assisting ...
(Date:3/15/2019)... ... 15, 2019 , ... The National Association of Chain Drug ... seven-day supply the initial prescriptions of opioids for acute pain – a move ... for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory ...
(Date:3/14/2019)... ... March 14, 2019 , ... When:    Wednesday, ... at Midtown - 1900 Long Beach Blvd., Long Beach, CA 90806 , What:    Los ... Housing, county and city officials, and other partners to celebrate the start of ...
Breaking Medicine News(10 mins):
(Date:3/14/2019)... ... 2019 , ... AxioMed announced today the issuance ... approval was received as a result of an accredited Notified Body assessment of ... clinical data regarding the viscoelastic AxioMed technology. , AxioMed first received CE ...
(Date:3/13/2019)... ... March 13, 2019 , ... Guard RFID Solutions Inc., a ... Tag (PT-3), a small and lightweight wearable RFID tag with a user-activated push ... in hazardous industrial environments. , “We have developed our most versatile tag to ...
(Date:3/13/2019)... ... March 13, 2019 , ... ... FocusOne Solutions ® has been recognized for its longevity as one of the ... has earned the Sustained Excellence Award which recognizes employers that have been ...
Breaking Medicine Technology:
Cached News: